Effect of initial management with aflibercept vs laser photocoagulation vs observation on vision loss among patients with diabetic macular oedema: a randomised clinical trial.
Create a free Member account at NZ Optics to read this article and more.
An Eye Institute seminar covered interpreting OCT for intraocular tumours and macular disease, photobiomodulation for dry AMD, pterygium management, retinal haemorrh
This article explains how buyers value an optometry practice for sale, focusing on adjusted EBITDA. It details key adjustments and levers like profitability and multiple that drive the
Professionalism for dispensing opticians encompasses clinical competence, interpersonal skills, and personal and practice presentation. Upholding these standards builds reputation, improves workplace relationships, and enhances business opportunities.
This article reviews advances in paediatric blepharokeratoconjunctivitis treatment, the cost-effectiveness of keratoconus screening and crosslinking
This month, Drew Jones covers Eye Institute’s Drs Peter Hadden’s and Sophie Hill’s responses to optometrists’ questions about vitrectomy recovery and counselling, anti-VEGF choices and emerging management options for geographic atrophy secondary to AMD. Answers have been abridged.
Patients with glaucoma are at high risk for developing dry eye disease (DED)1, with 40–59% of patients with glaucoma being diagnosed with DED worldwide2. DED in glaucoma is multifactorial and can be